Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Frontiers of Medicine|May 2, 2023
Progress and challenges in RET-targeted cancer therapyXueqing Hu, Ujjwol Khatri, Tao Shen, et al.Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|March 29, 2023
The heterogeneous transition state of resistance to RET kinase inhibitors converges on ERK1/2-driven Aurora A/B kinasesXueqing Hu, Xuan Liu, Ujjwol Khatri, et al.RNA Biology|February 27, 2019
The origin of exosomal miR-1246 in human cancer cellsYi-Fan Xu, Bethany N Hannafon, Ujjwol Khatri, et al.Cancer Letters|January 8, 2025
Selpercatinib mitigates cancer cachexia independent of anti-tumor activity in the HT1080 tumor modelUjjwol Khatri, Mohamed A Gouda, Shriya Pandey, et al.Molecular Cancer Therapeutics|April 18, 2023
Targeting RET Solvent-Front Mutants with Alkynyl Nicotinamide-Based InhibitorsUjjwol Khatri, Neetu Dayal, Xueqing Hu, et al.Journal of Medicinal Chemistry|December 26, 2024
Targeting Oncogenic RET Kinase by Simultaneously Inhibiting Kinase Activity and Degrading the ProteinYafeng Wang, Xueqing Hu, Shriya Pandey, et al.RSC Medicinal Chemistry|June 11, 2025
Identification of alkynyl nicotinamide HSN748 as a RET solvent-front mutant inhibitor with intracranial efficacyUjjwol Khatri, Neetu Dayal, Kofi B Owusu, et al.Pageof 1